development and controversy of competitive endogenous RNA hypothesis in non-coding genes

development and controversy of competitive endogenous RNA hypothesis in non-coding genes

RNA silencing of hormonal biosynthetic genes impairs larval progress and improvement in cotton bollworm, Helicoverpa armigera

The cotton bollworm, Helicoverpa armigera, is a extremely polyphagous pest, inflicting monumental losses to numerous economically vital crops. The identification and in vitro useful validation of goal genes of a pest is a prerequisite to fight pest through host-mediated RNA interference (RNAi).

Within the current examine, six hormonal biosynthesis genes of H. armigera had been chosen and evaluated by feeding insect larvae with dsRNAs corresponding to every goal gene, viz., juvenile hormone acid methyltransferase (HaJHAMT), prothoracicotropic hormone (HaPTTH), pheromone biosynthesis-activating peptide (HaPBAP), molt regulating transcription issue (HaHR3), activated protein 4 (HaAP-4) and eclosion hormone precursor (HaEHP).

The lack of perform phenotypes for these hormonal genes had been noticed by releasing second instar larvae on to synthetic weight loss program containing goal gene-specific dsRNAs. Ingestion of dsRNAs resulted in mortality starting from 60% to 90%, decreased larval weight, phenotypic deformities and delayed pupation. The quantitative real-time PCR (qRT-PCR) evaluation confirmed that the goal gene transcript ranges had been decreased drastically (31% to 77%) as in comparison with management or unrelated management (GFP-dsRNA), and correlated nicely with the mortality and developmental defects of larvae.

Additionally, a comparability of the silencing efficacy of un-diced lengthy HaPTTH -dsRNAwith RNase III diced HaPTTH-dsRNA (siRNAs) revealed that lengthy dsRNAs had been extra environment friendly in silencing the goal gene. These outcomes indicated that the hormonal biosynthesis genes have different sensitivity in direction of RNAi and could possibly be the very important targets for insect resistance in crop vegetation like cotton that are infested by H. armigera.

The event and controversy of aggressive endogenous RNA speculation in non-coding genes

As a momentous post-transcriptional regulator, microRNAs (miRNAs) are attracting an increasing number of consideration. The classical miRNAs regulated mechanism reveals it binds to the targets’ 3’UTR thus play the position in post-transcription.

In the meantime, single miRNA can goal a number of genes, so these ought to compete to bind that miRNA. Vice versa, single gene can sponge mass of miRNAs as nicely. Thus the aggressive endogenous RNAs (ceRNAs) speculation was put ahead in 2011.

The ceRNA speculation has made large achievements, specifically in non-coding genes, which together with lengthy non-coding RNAs (lncRNAs), circle RNAs (circRNAs) and pseudogenes, even viral transcripts. It additionally contributed enormously to epigenetics improvement.

Nonetheless, an growing variety of controversies have occurred with applause. Primarily based on this case, this evaluate introduces one thing intimately concerning the ceRNAs speculation achieved in lncRNAs,circRNAs, pseudogenes and viral transcripts, respectively. In the meantime, it additionally covers controversy of the ceRNAs speculation

geknome
geknome

Transcription Factor P65 (NFKB3) Antibody

abx038310-100ug 100 ug
EUR 469.2

Transcription Factor P65 (NFKB3) Antibody

abx037885-100g 100 µg
EUR 337.5

Transcription Factor P65 (NFKB3) Antibody

abx038310-1mg 1 mg
EUR 337.5

Transcription Factor P65 (NFKB3) Polyclonal Antibody

CAU27518-100ul 100ul
EUR 217.9

Transcription Factor P65 (NFKB3) Polyclonal Antibody

CAU27518-200ul 200ul
EUR 272.2

Transcription Factor P65 (NFKB3) Polyclonal Antibody

CAU27519-100ul 100ul
EUR 212.2

Transcription Factor P65 (NFKB3) Polyclonal Antibody

CAU27519-200ul 200ul
EUR 265.4

Polyclonal Antibody to Transcription Factor P65 (NFKB3)

PAA616Hu01 100ul
EUR 221

Polyclonal Antibody to Transcription Factor P65 (NFKB3)

PAA616Mu01 100ul
EUR 227

Polyclonal Antibody to Transcription Factor P65 (NFKB3)

PAA616Ra01 100ul
EUR 239

Anti-NFKB3 Antibody

39294 100ul
EUR 479

Anti-NFKB3 Antibody

Y058181 100 µl
EUR 145

anti- NFKB1 antibody

FNab10143 100µg
EUR 606.3
Description: Antibody raised against NFKB1

anti- NFKB1 antibody

FNab05702 100µg
EUR 606.3
Description: Antibody raised against NFKB1

anti- NFKB1 antibody

FNab05703 100µg
EUR 702
Description: Antibody raised against NFKB1

anti- NFKB2 antibody

FNab05705 100µg
EUR 606.3
Description: Antibody raised against NFKB2

anti- NFKB2 antibody

FNab05706 100µg
EUR 658.5
Description: Antibody raised against NFKB2

Anti- p52 (NFkB2) Antibody

GWB-AB58EB 0.1 ml Ask for price

Anti- p50 (NFKB1) Antibody

GWB-747B10 0.1 ml Ask for price

Recombinant Transcription Factor P65 (NFKB3)

RPU54244-100ug 100ug
EUR 589.6

Recombinant Transcription Factor P65 (NFKB3)

RPU54244-1mg 1mg
EUR 2610.4

Recombinant Transcription Factor P65 (NFKB3)

RPU54244-50ug 50ug
EUR 473

Recombinant Transcription Factor P65 (NFKB3)

RPU44376-100ug 100ug
EUR 393.8

Recombinant Transcription Factor P65 (NFKB3)

RPU44376-1mg 1mg
EUR 1747.2

Recombinant Transcription Factor P65 (NFKB3)

RPU44376-50ug 50ug
EUR 316.8

Recombinant Transcription Factor P65 (NFKB3)

RPU55569-100ug 100ug
EUR 918.5

Recombinant Transcription Factor P65 (NFKB3)

RPU55569-1mg 1mg
EUR 3606.2

Recombinant Transcription Factor P65 (NFKB3)

RPU55569-50ug 50ug
EUR 554.9

Recombinant Transcription Factor P65 (NFKB3)

RPA616Fi01 10ug
EUR 231

Recombinant Transcription Factor P65 (NFKB3)

RPA616Hu01 10ug
EUR 191

Recombinant Transcription Factor P65 (NFKB3)

RPA616Mu01 10ug
EUR 128

Anti-NFKB p50 (NFKB1) Antibody

GWB-CC6745 100 ul Ask for price

Human Transcription factor p65 protein (NFKB3)

1-CSB-RP039844h
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Transcription factor p65 protein(NFKB3),partial expressed in E.coli

Human Transcription factor p65 protein (NFKB3)

1-CSB-RP039874h
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Transcription factor p65 protein(NFKB3),partial expressed in E.coli

Anti-NFkB p105/p50/NFKB1 Antibody

PB9149 100ug/vial
EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody

PB9150 100ug/vial
EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody

PA1946 100ug/vial
EUR 400.8

Anti-NFkB p100/p52/NFKB2 Antibody

PA1946-1 100ug/vial
EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111 100ug/vial
EUR 352.8

Anti-NFkB p105/p50/NFKB1 Antibody

PA2111-1 100ug/vial
EUR 352.8

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKU08193-48T 48T
EUR 542.78

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKU08193-5x96T 5x96T
EUR 3683.15

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKU08193-96T 96T
EUR 775.4

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKN49304-48T 48T
EUR 337.82

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKN49304-5x96T 5x96T
EUR 2292.35

Rat Transcription Factor P65 (NFKB3) ELISA Kit

EKN49304-96T 96T
EUR 482.6

ELISA Kit for Transcription Factor P65 (NFKB3)

SEA616Hu 96Т
EUR 630

ELISA Kit for Transcription Factor P65 (NFKB3)

SEA616Ra 96Т
EUR 684

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU11278-48T 48T
EUR 600.25

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU11278-5x96T 5x96T
EUR 4073.13

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU11278-96T 96T
EUR 857.5

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU08192-48T 48T
EUR 500.5

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU08192-5x96T 5x96T
EUR 3396.25

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKU08192-96T 96T
EUR 715

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN49303-48T 48T
EUR 311.15

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN49303-5x96T 5x96T
EUR 2111.38

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN49303-96T 96T
EUR 444.5

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN52389-48T 48T
EUR 373.38

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN52389-5x96T 5x96T
EUR 2533.65

Human Transcription Factor P65 (NFKB3) ELISA Kit

EKN52389-96T 96T
EUR 533.4

Anti- cRel (NFkB) Antibody

GWB-393707 0.1 ml Ask for price

anti- NFKB1,p105,p50-Specific antibody

FNab05704 100µg
EUR 702
Description: Antibody raised against NFKB1,p105,p50-Specific

anti- NFKB2,p52,p100-Specific antibody

FNab05707 100µg
EUR 658.5
Description: Antibody raised against NFKB2,p52,p100-Specific

anti- NFKBIE antibody

FNab05708 100µg
EUR 658.5
Description: Antibody raised against NFKBIE

anti- NFKBIZ antibody

FNab05709 100µg
EUR 606.3
Description: Antibody raised against NFKBIZ

Pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx361108-96tests 96 tests
EUR 990

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx255851-96tests 96 tests
EUR 801.6

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

20-abx156040
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx255851-1096tests 10 × 96 tests Ask for price

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx255851-596tests 5 × 96 tests Ask for price

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx156040-100g 100 µg
EUR 6075

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx156040-10g 10 µg
EUR 675

Rat Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx156040-50g 50 µg
EUR 3212.5

Rabbit Anti-Human NFKB1 (aa 930-934) Polyclonal Antibody

CPB-1129RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 (aa 160-170) Polyclonal Antibody

CPB-1169RH 100 ul
EUR 552

Rabbit Anti-Human NFKB2 (aa 160-171) Polyclonal Antibody

CPB-1176RH 100 ul
EUR 552

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx570125-96tests 96 tests
EUR 801.6

Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx570127-96tests 96 tests
EUR 801.6

Sheep Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx364265-96tests 96 tests
EUR 1111.2

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx252815-96tests 96 tests
EUR 801.6

Mouse Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx254289-96tests 96 tests
EUR 801.6

Human Transcription factor p65 / NFKB3 (RELA) ELISA Kit

20-abx152945
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Rabbit Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx362582-96tests 96 tests
EUR 990

Monkey Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx359107-96tests 96 tests
EUR 990

Chicken Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx357192-96tests 96 tests
EUR 990

Chicken Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx357192-1096tests 10 × 96 tests Ask for price

Chicken Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx357192-596tests 5 × 96 tests
EUR 662.5

Rabbit anti IkBa (NFKB1A) Polyclonal Antibody

TA354676 100 µg Ask for price

Transcription Factor P65 (NFKB3) Magnetic Luminex Assay Kit

LKU602130-96T 96T
EUR 869.4

Transcription Factor P65 (NFKB3) Magnetic Luminex Assay Kit

LKU602133-96T 96T
EUR 944.2

Guinea pig Transcription factor p65 / NFKB3 (RELA) ELISA Kit

abx357262-96tests 96 tests
EUR 990

Rabbit Anti-Human NFKB2 Polyclonal Antibody, aa.864-868

CPB-930RH 100 ul
EUR 552

Rabbit Anti-Human NFKB2 Polyclonal Antibody, aa.868-872

CPB-931RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.335-339

CPB-932RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.891-895

CPB-933RH 100 ul
EUR 552

Rabbit Anti-Human NFKB1 Polyclonal Antibody, aa.905-909

CPB-934RH 100 ul
EUR 552

Mini Samples ELISA Kit for Transcription Factor P65 (NFKB3)

MEA616Hu 96Т
EUR 756

Rabbit anti IkBa (pS32/36) (NFKB1A) Polyclonal Antibody

TA354674 100 µg Ask for price

Anti- NFkB p65 (Rel A) Antibody

GWB-34C0DE 0.1 ml Ask for price

NFKB1 antibody

10R-11003 100 ug
EUR 344
Description: Mouse monoclonal NFKB1 antibody

NFKB1 antibody

10R-11155 100 ug
EUR 344
Description: Mouse Monoclonal NFKB1 antibody

NFKB2 antibody

10R-1605 100 ug
EUR 614.4
Description: Mouse monoclonal NFKB2 antibody

NFKB1 antibody

20-PR03 100 ul Ask for price
Description: Rabbit polyclonal NFKB1 antibody

NFKB1 Antibody

35588 100ul
EUR 319

NFKB1 Antibody

35588-100ul 100ul
EUR 302.4

NFKB2 antibody

38583 100ul
EUR 439

NFKB2 antibody

38583-100ul 100ul
EUR 302.4

NFKB1 antibody

39087 100ul
EUR 439

NFKB1 antibody

39087-100ul 100ul
EUR 302.4

NFKB1 Antibody

1-CSB-PA015759GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB2 Antibody

1-CSB-PA015760GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB

NFKB1 Antibody

E035588 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFKB2 Antibody

E037182 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NFKB2 Antibody

E19-7190 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

E10-30224 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

E10-30234 100μg/100μl
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

F47079-0.4ML 0.4 ml
EUR 322.15
Description: This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene.

NFKB2 Antibody

F47541-0.4ML 0.4 ml
EUR 322.15
Description: NF-kappa-B has been detected in numerous cell types that express cytokines, chemokines, growth factors, cell adhesion molecules, and some acute phase proteins in health and in various disease states. NF-kappa-B is activated by a wide variety of stimuli, such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. Inappropriate activation of NF-kappa-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and AIDS. In contrast, complete and persistent inhibition of NF-kappa-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth. NFKB1 (MIM 164011) and NFKB2 encode p105 and p100 proteins that are processed to produce the active p50 and p52 NF-kappa-B subunits, respectively. However, the p100 and p105 proteins serve regulatory functions and should not be considered exclusively as precursor forms. The most abundant activated form of NF-kappa-B is a heterodimer of the p50 or p52 subunit bound to the RELA subunit (MIM 164014). Other NF-kappa-B complexes, consisting of hetero- and homodimers of p50, p52, RELA, REL (MIM 164910), and RELB (MIM 604758), have also been detected. NF-kappa-B complexes are inhibited by I-kappa-B proteins, NFKBIA (MIM 164008) or NFKBIB (MIM 604495), which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by the kinases IKBKA (CHUK; MIM 600664) or IKBKB (MIM 603258) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. The activated NF-kappa-B complex translocates into the nucleus and binds DNA at kappa-B-binding motifs, such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine). For reviews, see Chen et al. (1999) [PubMed 9895331] and Baldwin (1996) [PubMed 8717528].

NFKB1 Antibody

F52441-0.4ML 0.4 ml
EUR 330.65
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NFkB is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NFkB complexes are held in the cytoplasm in an inactive state complexed with members of the NFkB inhibitor (I-kappa-B) family. In a conventional activation pathway, IkB is phosphorylated by IkB kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NFkB complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NFkB p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NFkB proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.

NFKB1 Antibody

E96667 100ul
EUR 255
Description: Available in various conjugation types.

NFKB1 Antibody

E911160 100ul
EUR 255
Description: Available in various conjugation types.

NFKB2 Antibody

E93108 100ul
EUR 255
Description: Available in various conjugation types.

NFKB1 Antibody

F54028-0.1ML 0.1 ml
EUR 322.15
Description: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. [UniProt]

NFKB2 Antibody

GWB-1BEED1 0.05 mg Ask for price

NFKB1 antibody

E39-05702 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 antibody

E39-05703 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB2 antibody

E39-05706 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 antibody

E39-10334 100ug/100ul
EUR 225
Description: Available in various conjugation types.

NFKB1 Antibody

E300225 200ul
EUR 275
Description: Available in various conjugation types.

NFKB2 Antibody

1-CSB-PA003428
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.IF:1/200-1/1000.ELISA:1/20000

NFKB2 Antibody

1-CSB-PA003429
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB2. Recognizes NFKB2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

NFKB1 Antibody

1-CSB-PA003430
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/10000

NFKB1 Antibody

1-CSB-PA003431
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NFKB1. Recognizes NFKB1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/40000

Conserved Patterns in Developmental Processes and Phases, Moderately than Genes, Unite the Extremely Divergent Bilateria

Bilateria are the predominant clade of animals on Earth. Regardless of having developed all kinds of physique plans and developmental modes, they’re characterised by frequent morphological traits. By default, researchers have tried to hyperlink clade-specific genes to those traits, thus distinguishing bilaterians from non-bilaterians, by their gene content material.

Right here we argue that it’s reasonably organic processes that unite Bilateria and set them aside from their non-bilaterian sisters, with a much less advanced physique morphology. To check this speculation, we in contrast proteomes of bilaterian and non-bilaterian species in an elaborate computational pipeline, aiming to seek for a set of bilaterian-specific genes.

Regardless of the restricted confidence of their bilaterian specificity, we nonetheless detected Bilateria-specific useful and developmental patterns within the sub-set of genes conserved in distantly associated Bilateria. Utilizing a novel multi-species GO-enrichment methodology, we decided the useful repertoire of genes which can be broadly conserved amongst Bilateria. Analyzing expression profiles in three very distantly associated mannequin species-D. melanogasterD. rerio and C. elegans-we discover attribute peaks at comparable phases of improvement and a delayed onset of expression in embryos. Specifically, the expression of the conserved genes seems to peak on the phylotypic stage of various bilaterian phyla.

In abstract, our examine illustrate how improvement connects distantly associated Bilateria after thousands and thousands of years of divergence, pointing to processes doubtlessly separating them from non-bilaterians. We argue that evolutionary biologists ought to return from a purely gene-centric view of evolution and place extra concentrate on analyzing and defining conserved developmental processes and durations.

Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence rating as an exemplar

Goal: Ladies with early-stage, ER + breast most cancers are advocate to obtain genomic profiling assessments, corresponding to the 21-gene Recurrence Rating (RS) check, to information therapy choices. We examined test- and treatment-related data mentioned and the associations between RS classes and facets of communication throughout patient-oncologist medical encounters.

Strategies: As half of a bigger trial, medical encounters (N = 46) had been audiorecorded and coded for 1) RS- and treatment-related data, 2) shared determination making, 3) affected person lively participation, and 4) oncologist patient-centered communication. We examined variations by RS class utilizing blended fashions, adjusting for nesting inside oncologist.

Outcomes: Sufferers with a excessive RS had been extra more likely to obtain a chemotherapy advice (p < .01), hear concerning the dangers/uncomfortable side effects of chemotherapy (p < .01), and supply their preferences (p = .02) than these with intermediate or low RS. Parts of shared determination making elevated with RS. Oncologist patient-centered communication (M = 4.09/5, SD = .25) and affected person lively participation (M = 3.5/4, SD = 1.0) had been excessive throughout RS.

Conclusion: Findings counsel that illness severity, reasonably than medical uncertainty, affect therapy suggestions and shared determination making.

Apply implications: Oncologists alter test- and treatment-related data and shared determination making by illness severity. This data offers a framework to tell determination making in advanced most cancers and genomics settings.

CRISPR-Cas, a strong gene-editing know-how within the period of recent most cancers immunotherapy

Most cancers immunotherapy has been emerged as a promising technique for therapy of a broad spectrum of malignancies starting from hematological to stable tumors. One of many principal approaches of most cancers immunotherapy is switch of pure or engineered tumor-specific T-cells into sufferers,

a so known as “adoptive cell switch”, or ACT, course of. Development of allogeneic T-cells relies on the employment of a gene-editing device to switch donor-extracted T-cells and put together them to particularly act in opposition to tumor cells with enhanced perform and sturdiness and least side-effects. On this context, CRISPR know-how can be utilized to provide common T-cells, outfitted with recombinant T cell receptor (TCR) or chimeric antigen receptor (CAR), by means of multiplex genome engineering utilizing Cas nucleases.

The sturdy potential of CRISPR-Cas in getting ready the constructing blocks of ACT immunotherapy has broaden the appliance of such therapies and a few of them have gotten FDA approvals. Right here, we’ve collected the final investigations within the area of immuno-oncology performed in partnership with CRISPR know-how. As well as, research which have addressed the challenges within the path of CRISPR-mediated most cancers immunotherapy, in addition to pre-treatment purposes of CRISPR-Cas have been talked about intimately.

 

c-Myc Epitope (Myc) Antibody

abx130438-200l 200 µl Ask for price

c-Myc(MYC275) Antibody

BNC810275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC810275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC810699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC810699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC810909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC810909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC800699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC800699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC800909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC800909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC430275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC430275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC430699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC430699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC430909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC430909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC050275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC050275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC050909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC050909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC550275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC550275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC550699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC550699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC550909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC550909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC700699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC700699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC700909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC700909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC800275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC800275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC610275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC610275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC610699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNC610699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC610909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNC610909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC700275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNC700275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCP0275-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC275), PerCP conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCP0699-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC699), PerCP conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCP0909-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC909), PerCP conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCR0275-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC275), RPE conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCR0699-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC699), RPE conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCR0909-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC909), RPE conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCA0275-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC275), APC conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCA0699-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC699), APC conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCA0909-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc(MYC909), APC conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCAP0275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCAP0275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCAP0699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCAP0699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCAP0909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCAP0909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCH0275-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC275), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC275) Antibody

BNCH0275-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC275), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCH0699-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC699), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC699) Antibody

BNCH0699-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC699), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCH0909-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc(MYC909), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc(MYC909) Antibody

BNCH0909-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc(MYC909), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc (MYC) rabbit polyclonal antibody

RA25085-100 100 µl Ask for price

Polyclonal MYC / c-Myc Antibody (aa25-74)

APR02915G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MYC / c-Myc (aa25-74). This antibody is tested and proven to work in the following applications:

c-Myc (MYC) rabbit polyclonal antibody, HRP

R1182HRP 100 µg Ask for price

Monoclonal MYC / c-Myc Antibody (aa408-420)

AMM02198G 0.05mg
EUR 580.8
Description: A Monoclonal antibody against Human MYC / c-Myc (aa408-420). The antibodies are raised in Mouse. This antibody is applicable in IHC-P, E

Polyclonal MYC / c-Myc Antibody (aa386-435)

APR02947G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MYC / c-Myc (aa386-435). This antibody is tested and proven to work in the following applications:

c-Myc (MYC) chicken polyclonal antibody, FITC

AP31790FC-N 1 ml Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx118000
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx139766-01mg 0.1 mg
EUR 460.8

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx133153
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx133248
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx133250
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx133912
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx137079
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx037911-100ug 100 ug
EUR 469.2

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx018354-100ug 100 ug
EUR 594

Myc Proto-Oncogene (C-Myc Peptide) Antibody

abx023934-100ug 100 ug
EUR 376.8

Myc Proto-Oncogene (C-Myc Peptide) Antibody

abx023935-01ml 0.1 ml
EUR 376.8

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx008959
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

20-abx008960
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx022462-02mg 0.2 mg
EUR 627.6

Myc Proto-Oncogene (c-Myc Peptide) Antibody

abx022463-02mg 0.2 mg
EUR 610.8

Myc Proto-Oncogene Protein (c-MYC) Antibody

abx231791-100ug 100 ug
EUR 661.2

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413504-01mg 0.1 mg
EUR 760.8

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413821-1mg 1 mg
EUR 994.8

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413825-2mg 2 mg
EUR 1830

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413826-01mg 0.1 mg
EUR 493.2

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413829-20ug 20 ug
EUR 326.4

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448567-100ug 100 ug
EUR 627.6

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448568-100ug 100 ug
EUR 627.6

c-Myc (MYC) rabbit polyclonal antibody, Biotin

R1182B 100 µg Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx118000-100l 100 µl Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx118000-20l 20 µl
EUR 287.5

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx118000-50l 50 µl
EUR 362.5

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx037911-01mg 0.1 mg
EUR 337.5

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx018354-1mg 1 mg
EUR 400

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx137079-01mg 0.1 mg
EUR 487.5

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx139766-100g 100 µg
EUR 300

Myc Proto-Oncogene Protein (c-MYC) Antibody

abx231791-100g 100 µg
EUR 350

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448567-1096tests 10 × 96 tests Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448567-596tests 5 × 96 tests Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448567-96tests 96 tests
EUR 550

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448568-1096tests 10 × 96 tests Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448568-596tests 5 × 96 tests Ask for price

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx448568-96tests 96 tests
EUR 550

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413504-200l 200 µl
EUR 550

Myc Proto-Oncogene Protein (c-Myc) Antibody

abx413829-200l 200 µl
EUR 175

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC801269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC801269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF680 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC811269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC811269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF680R conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC431269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC431269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF543 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC051269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC051269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF405M conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC551269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC551269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF555 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC701269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC701269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF770 conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC611269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNC611269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), CF660R conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCP1269-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), PerCP conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCR1269-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), RPE conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCA1269-250 250uL
EUR 459.6
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), APC conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCH1269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCH1269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCAP1269-100 100uL
EUR 238.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

c-Myc Oncoprotein (MYC275 + MYC909) Antibody

BNCAP1269-500 500uL
EUR 652.8
Description: Primary antibody against c-Myc Oncoprotein ( MYC275 + MYC909), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

C-Myc Antibody

6767-100 each
EUR 379.2

C-myc antibody

10R-C101a 100 ug Ask for price
Description: Mouse monoclonal C-myc antibody

C-myc antibody

20R-CC001 200 ug
EUR 372
Description: Chicken polyclonal C-myc antibody

C-myc Antibody

48044 100ul
EUR 429

C-myc Antibody

48044-100ul 100ul
EUR 399.6

C-myc Antibody

48044-50ul 50ul
EUR 286.8

C-Myc Antibody

3995-100 each
EUR 392.4

C-Myc Antibody

3995-30T each
EUR 175.2

C-myc Antibody

E80912-2 100ul
EUR 225
Description: Available in various conjugation types.

C-MYC Antibody

E90045 100ul
EUR 225
Description: Available in various conjugation types.

c-Myc Antibody

E38PA4748 100ul
EUR 225
Description: Available in various conjugation types.

c-Myc Antibody

E559008-2B2-PU 100ug
EUR 295
Description: Available in various conjugation types.

c-Myc Antibody

E38PA1777 100ul
EUR 225
Description: Available in various conjugation types.

c-Myc Antibody

E38PA1778 100ul
EUR 225
Description: Available in various conjugation types.

c-Myc Antibody

E38PA4474 100ul
EUR 225
Description: Available in various conjugation types.

c-Myc Antibody

E300871 100ug/200ul
EUR 275
Description: Available in various conjugation types.

c-MYC antibody

CAF50652-100ug 100ug
EUR 312

C-myc antibody

70R-10651 1 ml
EUR 460
Description: Affinity purified Chicken polyclonal C-myc antibody

c-Myc antibody

70R-32862 100 ug
EUR 422
Description: Rabbit polyclonal c-Myc antibody

C-myc antibody

70-CC18 100 ug
EUR 279
Description: Affinity purified Chicken polyclonal C-myc antibody

C-myc antibody

70R-CG001 100 ul
EUR 461
Description: Affinity purified Goat polyclonal C-myc antibody

c-Myc Antibody

AF0358 200ul
EUR 420

c-Myc Antibody

AF6054 200ul
EUR 420

c-Myc Antibody

AF6054-100ul 100ul
EUR 280

c-Myc Antibody

AF6054-200ul 200ul
EUR 350

c-Myc Antibody

AF6055 200ul
EUR 420

Leave a Reply

Your email address will not be published. Required fields are marked *